Edition:
United States

Koninklijke DSM NV (RDSMY.PK)

RDSMY.PK on OTC Markets Group

18.51USD
3:58pm EDT
Change (% chg)

$0.01 (+0.05%)
Prev Close
$18.50
Open
$18.49
Day's High
$18.54
Day's Low
$18.43
Volume
34,957
Avg. Vol
51,436
52-wk High
$18.76
52-wk Low
$13.46

Latest Key Developments (Source: Significant Developments)

DSM announces Thermo Fisher will commence tender offer to acquire all shares of Patheon
Monday, 15 May 2017 07:19am EDT 

May 15 (Reuters) - KONINKLIJKE DSM NV ::INFORMS MARKET ON PATHEON N.V..BOARD OF DIRECTORS OF PATHEON N.V., COMPANY IN WHICH DSM HOLDS APPROXIMATELY 48.7 MILLION ORDINARY SHARES, UNANIMOUSLY APPROVED ACQUISITION OF PATHEON BY THERMO FISHER SCIENTIFIC INC..THERMO FISHER WILL COMMENCE A TENDER OFFER TO ACQUIRE ALL OF THE ISSUED AND OUTSTANDING SHARES OF PATHEON FOR $35.00 PER ORDINARY SHARE IN CASH.ENTERED INTO TENDER AND SUPPORT AGREEMENT WITH THERMO FISHER PURSUANT TO WHICH DSM WILL TENDER ITS SHARES IN TRANSACTION, WHICH IS EXPECTED TO BE COMPLETED BY END OF 2017.  Full Article

DSM coating resins announces price increases for its liquid coating resins
Thursday, 11 May 2017 12:17pm EDT 

May 11 (Reuters) - KONINKLIJKE DSM NV :KONINKLIJKE DSM NV - DSM COATING RESINS ANNOUNCES PRICE INCREASES FOR ITS LIQUID COATING RESINS.  Full Article

DSM to make equity investment in Amyris
Monday, 8 May 2017 08:41am EDT 

May 8 (Reuters) - DSM ::ROYAL DSM TO MAKE EQUITY INVESTMENT IN AMYRIS <<>> WITH THE PURPOSE OF ESTABLISHING A LONG-TERM RELATIONSHIP.AGREED TO MAKE AN INITIAL EQUITY INVESTMENT IN AMYRIS OF US$25 MILLION, TRANSLATING INTO A SHAREHOLDING OF ABOUT 12 PCT.SUBJECT TO THE SATISFACTION OF CERTAIN CONDITIONS, DSM MAY INVEST AN ADDITIONAL US$25 MILLION IN AMYRIS.FIRST TRANCHE IS EXPECTED TO CLOSE ON MAY 11 2017, WITH SECOND TRANCHE, IF APPROVED BY DSM’S MANAGING BOARD, EXPECTED TO CLOSE WITHIN 90 DAYS OF CLOSING OF FIRST TRANCHE.  Full Article

Amyris announces agreements for up to $95 mln in equity financing
Monday, 8 May 2017 08:30am EDT 

May 8 (Reuters) - Amyris Inc :Amyris announces agreements for up to $95 million in equity financing and in-process initiative to significantly reduce debt.Equity financing commitment includes participation by Koninklijke DSM N.V., DSM agreed to initial equity investment in Co of $25 million.Subject to satisfaction of certain conditions, DSM may invest an additional $25 million in Amyris.Is in process of reducing its debt by about $75 million, about $40 million of such amount is being converted pursuant to terms of equity financing.  Full Article

DSM Q1 EBITDA above Reuters consensus at 334 million euros
Tuesday, 2 May 2017 01:01am EDT 

May 2 (Reuters) - DSM ::Q1 EBITDA 334 million euros ($364.49 million) versus 329 million euros in Reuters poll.Q1 sales 2.16 billion euros versus 2.05 billion euros in Reuters poll.In 2017 DSM aims to deliver high-single digit percentage adjusted EBITDA growth.In 2017 aims to deliver high double-digit basis point roce growth in line with targets set out in its strategy 2018.We are confident that we will be able to deliver against our full-year objectives - CEO.  Full Article

DSM and ET Solar announce strategic partnership
Tuesday, 18 Apr 2017 03:03am EDT 

April 18 (Reuters) - Koninklijke DSM NV ::Co and ET Solar announce strategic partnership to accelerate market penetration of PV modules featuring sustainable and durable backsheets.  Full Article

E.ON and DSM Nutritional Products intend to modernize existing power plant
Wednesday, 12 Apr 2017 06:28am EDT 

E.ON SE : DSM Nutritional Products and E.ON have announced their intention to essentially modernize the existing distributed power plant at Grenzach-Wyhlen in Baden-Wuerttemberg .Contract for decentralized power generation extended for at least 15 years.  Full Article

DSM announces repurchase of shares to cover existing option plans and stock dividend
Monday, 13 Mar 2017 03:01am EDT 

Koninklijke DSM NV : Announces repurchase of shares to cover existing option plans and stock dividend . Intends to repurchase 2,900,000 ordinary shares starting on March 13, 2017 . Repurchase of shares to cover its commitments under existing management and personnel option plans (1,700,000) and shares for stock dividend as part of final dividend 2016 (1,200,000) .Based on the closing price of DSM share on Euronext Amsterdam on March 10, 2017 this repurchase of shares would be equivalent to about 185 million euros ($198.1 million).  Full Article

DSM and Evonik establish joint venture for Omega-3 fatty acids
Wednesday, 8 Mar 2017 02:00am EST 

Koninklijke DSM NV : DSM and Evonik establish joint venture for Omega-3 fatty acids from natural marine algae for animal nutrition . Nutritional products and Evonik nutrition & care will each hold a 50 percent share in joint venture . Evonik to co-own production facility, which will be built at an existing site of evonik and is expected to come on stream in 2019 . Joint venture plans to invest around USD 200 million in facility (USD 100 million by each party over circa 2 years) .Set-Up of joint venture, to be named Veramaris and headquartered in the Netherlands.  Full Article

By-health signs strategic cooperation agreement with Royal DSM N.V. China
Friday, 18 Nov 2016 03:00am EST 

By-health <300146.SZ>:Says it signed a strategic cooperation agreement with Royal DSM N.V. China.  Full Article

More From Around the Web

Thermo Fisher to buy Patheon for $5.2 bln to expand biopharma services

Thermo Fisher Scientific Inc said on Monday it would buy Patheon NV, a Dutch manufacturer of drugs for clinical trials, for $5.2 billion as it seeks to complement its offerings in production and services for the biopharma industry.